In addition, TDP-43 has been shown to disrupt the VAPB-PTPIP52 pathway; a similar mechanism is thought to exist in cases of idiopathic ALS, where pathogenic TDP-43 accumulates. This evidence concerns the gene VAPB and amyotrophic lateral sclerosis.